Research Article|Articles in Press

Evaluation of Safety After Intracordal Basic Fibroblast Growth Factor Injection



      Although there are many reports of voice improvement with intracordal trafermin (a basic fibroblast growth factor) injections under local anesthesia, few papers have documented the safety of trafermin. Therefore, we aimed to investigate whether trafermin is safer than control drugs (triamcinolone acetonide) early after intracordal injection under local anesthesia.


      We conducted a retrospective review from the medical records of patients who underwent intracordal injection with trafermin and triamcinolone acetonide under local anesthesia at our institution. Early postinjective complications were defined as changes in vital signs and chief complaints early after intracordal injection.


      A total of 699 and 297 patients underwent intracordal injection under local anesthesia with trafermin and triamcinolone acetonide, respectively. Of these, 227 and 130 patients had early postinjective complications with trafermin and triamcinolone acetonide, retrospectively. The most common complications occurring with trafermin was increased blood pressure in 39 cases (5.58%): 17 cases (2.43%) of blood pressure increase of ≥20 mm Hg. Other complications included pharyngeal discomfort in 37 (5.29%), lightheadedness in 33 (4.72%), and phlegm discharge in 29 (4.15%). Triamcinolone acetonide caused pharyngeal discomfort in 28 patients (9.43%), phlegm discharge in 17 patients (5.72%), lightheadedness in 12 patients (4.04%), sore throat in 11 patients (3.70%), increased blood pressure in 10 patients (3.37%): 7 cases (2.36%) of blood pressure increase of ≥20 mm Hg, and dizziness in seven patients (2.36%). Statistical analysis of the complications between trafermin and triamcinolone acetonide showed no significant differences.


      The proportion of early postinjective complications from intracordal injection of trafermin is no significant difference in that of triamcinolone acetonide. The results suggest that the early postinjective complications are not due to the drug action of trafermin, but rather to complications from the intracordal injection procedures. Intracordal trafermin injection may be safe in the short term.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Voice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Okumura M
        • Okuda T
        • Kataoka S
        • et al.
        Effects of recombinant human basic growth factor (bFGF) on wound fibroblast healing in comparison with some marketed drugs.
        Clin Rep. 1996; 30: 2161-2174
        • Tanaka E
        • Ase K
        • Okuda T
        • et al.
        Mechanism of acceleration of wound healing by basic fibroblast growth factor in genetically diabetic mice.
        Biol Pharm Bull. 1996; 19: 1141-1148
        • Okumura M
        • Okuda T
        • Nakamura T
        • et al.
        Acceleration of wound healing in diabetic mice by basic fibroblast growth factor.
        Biol Pharm Bull. 1996; 19: 530-535
        • Anzai J
        • Nagayasu-Tanaka T
        • Terashima A
        • et al.
        Long-term observation of regenerated periodontium induced by FGF-2 in the beagle dog 2-wall periodontal defect model.
        PLoS One. 2016; 11e0158485
        • Nagayasu-Tanaka T
        • Anzai J
        • Takaki S
        • et al.
        Action mechanism of fibroblast growth factor-2 (FGF-2) in the promotion of periodontal regeneration in beagle dogs.
        PLoS One. 2015; 10e0131870
        • Mondain M
        • Ryan A.
        Histological study of the healing of traumatic tympanic membrane perforation after basic fibroblast growth factor application.
        Laryngoscope. 1993; 103: 312-318
        • DeLapp NW
        • Dieckman DK.
        Effect of basic fibroblast growth factor (bFGF) and insulin-like growth factors type I (IGF-I) and type II (IGF-II) on adult human keratinocyte growth and fibronectin secretion.
        J Invest Dermatol. 1990; 94: 777-780
        • Mondain M
        • Ryan A.
        Effect of basic fibroblast growth factor on normal tympanic membrane.
        Am J Otolaryngol. 1994; 15: 344-350
        • Hirano S
        • Tateya I
        • Kishimoto Y
        • Kanemaru SI
        • Ito J.
        Clinical trial of regeneration of aged vocal folds with growth factor therapy.
        Laryngoscope. 2012; 122: 327-331
        • Hirano S
        • Mizuta M
        • Kaneko M
        • et al.
        Regenerative phonosurgical treatments for vocal fold scar and sulcus with basic fibroblast growth factor.
        Laryngoscope. 2013; 123: 2749-2755
        • Kanazawa T
        • Komazawa D
        • Indo K
        • et al.
        Single injection of basic fibroblast growth factor to treat severe vocal fold lesions and vocal fold paralysis.
        Laryngoscope. 2015; 125: E338-E344
        • Suzuki H
        • Makiyama K
        • Hirai R
        • et al.
        Efficacy of a single dose of basic fibroblast growth factor: clinical observation for 1 year.
        J Voice. 2016; 30: 761.e11-761.e17
        • Ohno S
        • Hirano S
        • Yasumoto A
        • et al.
        Outcome of regenerative therapy for age-related vocal fold atrophy with basic fibroblast growth factor.
        Laryngoscope. 2016; 126: 1844-1848
        • Kanazawa T
        • Kurakami K
        • Kashima K
        • et al.
        Injection of basic fibroblast growth factor for unilateral vocal cord paralysis.
        Acta Otolaryngol. 2017; 137: 962-967
        • Takeharu K
        • Kurakami K
        • Konomi U
        • et al.
        Safety and short-term outcomes of basic fibroblast growth factor injection for sulcus vocalis.
        Acta Otolaryngol. 2018; 138: 1014-1019
        • Okui A
        • Konomi U
        • Kanazawa T
        • et al.
        Therapeutic efficacy of basic fibroblast growth factor in patients with vocal fold atrophy.
        Laryngoscope. 2020; 130: 2847-2852
        • Hirano S
        • Sugiyama Y
        • Kaneko M
        • et al.
        Intracordal injection of basic fibroblast growth factor in 100 cases of vocal fold atrophy and scar.
        Laryngoscope. 2021; 131: 2059-2064
        • Miura R
        • Matsuzaki H
        • Suzuki H
        • et al.
        Effect of a single injection of basic fibroblast growth factor into the vocal folds: a 36-month clinical study.
        J Voice. 2021;
        • Sueyoshi S
        • Umeno H
        • Kurita T
        • et al.
        Long-term outcomes of basic fibroblast growth factor treatments in patients with vocal fold scarring, aged vocal fold, and sulcus vocalis.
        Auris Nasus Larynx. 2021; 48: 949-955
        • Takahashi S
        • Kanazawa T
        • Hasegawa T
        • et al.
        Comparison of therapeutic effects of steroid injection by benign vocal fold lesion type.
        Acta Otolaryngol. 2021; 141: 1005-1013
        • Tateya I
        • Omori K
        • Kojima H
        • et al.
        Steroid injection for Reinke's edema using fiberoptic laryngeal surgery.
        Acta Otolaryngol. 2003; 123: 417-420
        • Yung KC
        • Courey MS.
        The effect of office-based flexible endoscopic surgery on hemodynamic stability.
        Laryngoscope. 2010; 120: 2231-2236
        • Tamura E
        • Fukuda H
        • Tabata Y.
        Intracordal injection technique: materials and injection site.
        Tokai J Exp Clin Med. 2008; 33: 119-123
        • Hasegawa T
        • Kanazawa T
        • Komazawa D
        • et al.
        Effect of intracordal injection under local anesthesia on vital signs in high-risk patients.
        Auris Nasus Larynx. 2022; 49: 445-453
        • Presta M
        • Moscatelli D
        • Joseph-Silverstein J
        • et al.
        Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration.
        Mol Cell Biol. 1986; 6: 4060-4066
        • Gospodarowicz D
        • Ferrara N
        • Schweigerer L
        • et al.
        Structural characterization and biological functions of fibroblast growth factor.
        Endocr Rev. 1987; 8: 95-114
        • Saksela O
        • Moscatelli D
        • Rifkin DB.
        The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells.
        J Cell Biol. 1987; 105: 957-963
        • Folkman J
        • Klagsbrun M.
        Angiogenic factors.
        Science. 1987; 235: 442-447
        • Rifkin DB
        • Moscatelli D.
        Recent developments in the cell biology of basic fibroblast growth factor.
        J Cell Biol. 1989; 109: 1-6
        • Sheehan SM
        • Allen RE
        Skeletal muscle satellite cell proliferation in response to members of the fibroblast growth factor family and hepatocyte growth factor.
        J Cell Physiol. 1999; 181: 499-506≤499::AID-JCP14≥3.0.CO;2-1
        • Kimura Y
        • Ozeki M
        • Inamoto T
        • et al.
        Time course of de novo adipogenesis in matrigel by gelatin microspheres incorporating basic fibroblast growth factor.
        Tissue Eng. 2002; 8: 603-613
        • Tedesco FS
        • Dellavalle A
        • Diaz-Manera J
        • Messina G
        • Cossu G.
        Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells.
        J Clin Invest. 2010; 120: 11-19
        • Zammit PS
        • Partridge TA
        • Yablonka-Reuveni Z.
        The skeletal muscle satellite cell: the stem cell that came in from the cold.
        J Histochem Cytochem. 2006; 54: 1177-1191
        • Schultz E
        • Gibson MC
        • Champion T.
        Satellite cells are mitotically quiescent in mature mouse muscle: an EM and radioautographic study.
        J Exp Zool. 1978; 206: 451-456
        • Floss T
        • Arnold HH
        • Braun T.
        A role for FGF-6 in skeletal muscle regeneration.
        Genes Dev. 1997; 11: 2040-2051
        • Tatsumi R
        • Anderson JE
        • Nevoret CJ
        • et al.
        HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells.
        Dev Biol. 1998; 194: 114-128
        • Musarò A.
        Growth factor enhancement of muscle regeneration: a central role of IGF-1.
        Arch Ital Biol. 2005; 143: 243-248
        • Wozniak AC
        • Anderson JE.
        Nitric oxide-dependence of satellite stem cell activation and quiescence on normal skeletal muscle fibers.
        Dev Dyn. 2007; 236: 240-250
        • Lefaucheur JP
        • Gjata B
        • Lafont H
        • et al.
        Angiogenic and inflammatory responses following skeletal muscle injury are altered by immune neutralization of endogenous basic fibroblast growth factor, insulin-like growth factor-1 and transforming growth factor-beta 1.
        J Neuroimmunol. 1996; 70: 37-44
        • Aebischer P
        • Salessiotis AN
        • Winn SR.
        Basic fibroblast growth factor released from synthetic guidance channels facilitates peripheral nerve regeneration across long nerve gaps.
        J Neurosci Res. 1989; 23: 282-289
        • Peng HB
        • Baker LP
        • Chen Q.
        Induction of synaptic development in cultured muscle cells by basic fibroblast growth factor.
        Neuron. 1991; 6: 237-246
        • Grothe C
        • Meisinger C
        • Claus P.
        In vivo expression and localization of the fibroblast growth factor system in the intact and lesioned rat peripheral nerve and spinal ganglia.
        J Comp Neurol. 2001; 434: 342-357
        • Guthridge M
        • Wilson M
        • Cowling J
        • et al.
        The role of basic fibroblast growth factor in skeletal muscle regeneration.
        Growth Factors. 1992; 6: 53-63
        • Yeragani VK
        • Tancer M
        • Seema KP
        • et al.
        Increased pulse-wave velocity in patients with anxiety: implications for autonomic dysfunction.
        J Psychosom Res. 2006; 61: 25-31
        • Tetsu S
        • Kanazawa M
        • Narita H
        • et al.
        Influence of midazolam premedication after entering the operation room on blood pressure in hypertension patients.
        J Jpn Soc Clin Anesth. 2014; 34: 397-401
        • Nobuhara H
        • Hori S
        • Watoh Y
        • et al.
        Studies on the safety of intratracheal and intravenous administration of lidocaine. From comparison of blood concentration.
        J Clin Anesth (Japan). 1987; 11: 353-357
        • Nation RL
        • Triggs EJ
        • Selig M.
        Lignocaine kinetics in cardiac patients and aged subjects.
        Br J Clin Pharmacol. 1977; 4: 439-448
        • Kodama H
        • Kumai Y
        • Nishimoto K
        • et al.
        Modulation of satellite cells activity and MyoD in rat thyroarytenoid muscle after reinnervation.
        Laryngoscope. 2015; 125: E245-E251